<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50">
 <label>50.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baldo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Van</surname>
    <given-names>Den Akker E</given-names>
   </name>
   <name>
    <surname>Bergmans</surname>
    <given-names>HE</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Pauwels</surname>
    <given-names>K</given-names>
   </name>
  </person-group>. 
  <article-title>General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination</article-title>. 
  <source>Curr Gene Ther.</source> (
  <year>2013</year>) 
  <volume>13</volume>:
  <fpage>385</fpage>â€“
  <lpage>94</lpage>. 
  <pub-id pub-id-type="doi">10.2174/15665232113136660005</pub-id>
  <?supplied-pmid 24195604?>
  <pub-id pub-id-type="pmid">24195604</pub-id>
 </mixed-citation>
</ref>
